Pharmafile Logo
Pharmafocus logo
Advanced Search

$24 million in grants to help end HIV epidemic across the globe

March 30, 2022
Research and Development

Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, …

News

Margaret Keegan joins RQM+ as new CEO

March 29, 2022

RQM+, a world leading provider of regulatory, clinical and quality solutions to the MedTech industry, announced the appointment of life …

Appointment

Injecting real-world data into every day clinical trials – RWE and RWD

March 29, 2022

The past two years have seen unprecedented pressure on healthcare systems, its workers, and clinical research as a whole. COVID-19 …

Feature

Preparation Preconditions: What measures are needed to combat another pandemic?

March 29, 2022

Could we have foreseen the damage caused by the COVID-19 pandemic? This is a central question that has plagued biopharma …

Feature

CHMP recommends approval of Janssen’s first CAR-T therapy

March 29, 2022
Manufacturing and Production

Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of adults …

News

Telix granted FDA orphan drug designation for bone marrow conditioning treatment

March 29, 2022
Manufacturing and Production

The FDA has granted Orphan Drug Designation (ODD) for TLX66, for conditioning treatment prior to hematopoietic stem cell transplant (HSCT). …

News

Japan: drug approved for treatment of life-threatening bleeding

March 29, 2022
Manufacturing and Production

AstraZeneca has announced that Ondexxya has become the first approved medicine in Japan to reverse the anticoagulant effect of Factor …

News

BIMZELX effective for moderate to severe plaque psoriasis treatment

March 29, 2022
Manufacturing and Production

UCB has revealed results from its Phase III/IIIb trials of BIMZELX (bimekizumab) for the treatment of adults with moderate to …

News

NICE does not recommend icosapent ethyl for prevention of cardiovascular events

March 28, 2022
Sales and Marketing

NICE has published further draft guidance for public consultation which does not recommend VAZKEPA (icosapent ethyl) for reducing the risk …

News

FDA approve oral solution for rare childhood epilepsy

March 28, 2022
Sales and Marketing

UCB has announced that FINTEPLA® (fenfluramine) oral solution CIV has been approved by the FDA for the treatment of seizures …

News

EMA review first novel gene therapy candidate for haemophilia B

March 28, 2022
Sales and Marketing

CSL Behring has today announced that the EMA has accepted the Marketing Authorising Application for etranacogene dezaparvovec (EtranaDez), under its …

News

Pregnant women to receive life-saving pre-eclampsia check on NHS

March 28, 2022
Sales and Marketing

A life-saving blood test that can help diagnose suspected preterm pre-eclampsia has been recommended by NICE, and this is to …

News

After pressure from patients, ALS drug reviewed by FDA

March 25, 2022
Medical Communications

The FDA is meeting next week to review a drug closely watched for ALS, also known as Lou Gehrig’s disease, …

News

Angle PLC announces identifying therapeutic targets in TNBC patients

March 25, 2022
Medical Communications

A leading cancer research institute in Milan, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori, has published results of a study …

News

FDA grant Breakthrough Therapy Designation for RSV vaccine candidate in older adults

March 25, 2022
Medical Communications

Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate has received Breakthrough Therapy Designation from the FDA, for …

News

ViiV Healthcare announces label update for long-acting HIV treatment

March 25, 2022
Medical Communications

The FDA has approved a label update for Cabenuva (cabotegravir, rilpivirine), which makes the oral lead-in with cabotegravir and rilpivirine …

News

AstraZeneca cervical cancer treatment fails to meet endpoint in Phase III trial

March 24, 2022
Business Services

AstraZeneca has shared that results from its Calla Phase III trial of Imfinzi for the treatment of locally advanced cervical …

News

Spot the Difference: A Common Cold, or COVID-19?

March 24, 2022

Prior to the pandemic, if you got a runny nose and a sore throat, you would likely assume it was …

News

Novel therapy could revolutionise treatment for asthma, COPD, among others

March 24, 2022
Business Services

A multicenter research team in Texas has developed the first drug to treat the uncontrolled secretion of mucins in the …

News

FDA approval for castration-resistant prostate cancer

March 24, 2022
Business Services

The FDA has approved Novartis’ prostate cancer treatment, Pluvicto™, which is now expected to become available in a few weeks. …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026